Tonix Pharma

Developer of next-generation medicines for CNS and immunological disorders

placeNew York City, New York, United States calendar_todayFounded 2007 groups117 employees language tonixpharma.com

Registered entities

Innovation

23 patent families (14 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing; filing pace accelerating. Cited 1,543 times.

YearFilings
20162
20182
20191
20202
20215
20228
20234
20249
202513
20264

Social engagement

Social engagement: 23.3K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

4 investors on record.

Investor typeCountShare
Venture capital125%
Bank & private debt125%
Other / undisclosed250%

Recent activity

26 Jun 2026
Event
2026 American Association of Nurse Practitioners National Conference
23 Jun 2026
Event
BIO2026
11 Jun 2026
Event
BTIG's Infectious Disease Day 2026 conference
Coming soon